Dr. Dunnenberger is Director of Personalized Medicine and Pharmacogenomics in the Mark R. Neaman Center for Personalized Medicine at NorthShore University HealthSystem (NorthShore), and leads the various clinical pharmacogenomics implementation projects within the Center. The goal of these projects is to improve the care and health outcomes of NorthShore University HealthSystem patients through pharmacogenomics-based strategies. He joined NorthShore in 2014.
Dr. Dunnenberger leads the Pharmacogenomics Clinic, which serves as part of a system-wide initiative building upon the health system’s strong foundation in genetics and molecular medicine. The Clinic is among only a few across the country, and the first of its kind in the Chicagoland area that pre-emptively screens patients for responses to medications based on genetic makeup. His clinical expertise and research interests include translating pharmacogenomics into clinical practice, developing information technology solutions for delivering genetic information to both clinicians and patients in a practical manner, and evaluating methods for educating healthcare professionals about pharmacogenetics
Dr. Dunnenberger has co-authored numerous original publications, including multiple CPIC guidelines. He earned his PharmD from the University of Tennessee Health Science Center College of Pharmacy in 2012. He completed a PGY1 Pharmacy Practice Residency at Mission Hospital in Asheville, North Carolina, and a PGY2 Clinical Pharmacogenetics Residency in the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, Tennessee.
